BioCentury
ARTICLE | Company News

Hangzhou Just, MabSpace merging

January 2, 2019 9:03 PM UTC

Hangzhou Just Biotherapeutics Ltd. (Hangzhou, China) and MabSpace Biosciences Co. Ltd. (Hong Kong, China) announced on Tuesday that the companies will merge to create Transcenta Holding Ltd.

The companies said Transcenta will have a global footprint with clinical development centers in Boston, Shanghai and Beijing, a discovery and translational research center in Suzhou and a product development and manufacturing facility in Hangzhou. Transcenta will have over 10 candidates in its pipeline, including MabSpace’s MSB2311, a humanized IgG1 mAb targeting PD-L1 in Phase I testing to treat advanced solid tumors...